Entrada Therapeutics Inc. (TRDA)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New Form 8-K - ORAGENICS INC Filed: 2025-09-02 AccNo: 0001493152-25-012562 Size: 211 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference